Search our Innovation Portfolio

This project will demonstrate that delivering near-patient coagulopathy diagnostics into acute care will improve efficiency of use of resources within the hospital.  This project utilises the skills of NIHR Diagnostic Evidence Co-operative London (DEC) (Imperial College St. Marys Hospital) to gather stakeholder evidence and generate potential new pathways alongside economic cost modelling. Highland Biosciences Ltd (HBL) will gather expert insight and advance its technology to meet the challenge.

Managed by HBL, the project focuses on delivering new clinical approaches to the NHS whilst generating the evidence for a highly commercially attractive value proposition for a new diagnostic business.

IEG4 and Harrogate and District NHS Foundation Trust will co-produce and prototype a software solution to deliver personalised assessed outcomes to those patients, carers and families needing most support on discharge. Dramatically improving patient experience, improving efficiency and enabling system transformation.The proposed solution will focus on: Outcomes for patients not the needs of organisations. Streamlining online referrals and assessments. Facilitating the complete removal of paper and sharing outcomes with targeted support and care organisations and family / friends / volunteers. Matching resources in the community to patient needs allowing flexible and mobile remote working.

Cystic fibrosis (CF) is one of the UK's most common, life-shortening, genetically inherited diseases. There are currently more than 10,500 people in the UK with CF with an annual expenditure for CF in England of approx £100m, (£9,500 per patient). In the last 50 years there have been major advances in CF care, however each new therapy has added the heavy burden of treatment. The aim of this project is to investigate if a new model of care has the ability to engage children and adolescents with CF in self management and as a result, reduce the burden of care.